Table 2.
Cervicovaginal histopathology | Total/% | # SIV+ | # With gross lesions/total | Selected representative cases |
---|---|---|---|---|
Increased lymphoid aggregates | 89/27% | 68 | 2/89 | Case 13 |
Suppurative cervicitis and/or vaginitis | 38/12% | 24 | 14/38 | Cases 5, 6 |
Dilated/cystic mucosal glands | 12/4% | 5 | 6/12 | |
Metaplasia, hyperplasia, or dysplasia | 7/2% | 2 | 1/7 | Case 1 |
Vascular abnormalities | 6/2% | 4 | 0/6 | |
Vaginal/cervical polyp | 3/0.9% | 1 | 3/3 | Cases 2-4 |
Leiomyoma | 2/0.6% | 0 | 2/2 | |
Carcinoma | 1 | 1 | 1/1 | Case 7 |
Serosal granulosa cell tumor | 1 | 0 | 1/1 | |
Serosal endometriosis | 1 | 0 | 1/1 | |
Myonecrosis and regeneration | 1 | 1 | 0/1 | |
Pericervical abscess | 1 | 1 | 1/1 | |
Erosive vaginitis | 1 | 1 | 0/1 | |
Vaginal cryptosporidiosis | 1 | 1 | 0/1 | |
Vaginal foreign body | 1 | 1 | 1/1 | |
No significant findings | 165/50% | 105 | 0/165 | Cases 9-2 |